Literature DB >> 22461696

Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection.

Nívea F Luz1, Bruno B Andrade, Daniel F Feijó, Théo Araújo-Santos, Graziele Q Carvalho, Daniela Andrade, Daniel R Abánades, Enaldo V Melo, Angela M Silva, Cláudia I Brodskyn, Manoel Barral-Netto, Aldina Barral, Rodrigo P Soares, Roque P Almeida, Marcelo T Bozza, Valéria M Borges.   

Abstract

Visceral leishmaniasis (VL) remains a major public health problem worldwide. This disease is highly associated with chronic inflammation and a lack of the cellular immune responses against Leishmania. It is important to identify major factors driving the successful establishment of the Leishmania infection to develop better tools for the disease control. Heme oxygenase-1 (HO-1) is a key enzyme triggered by cellular stress, and its role in VL has not been investigated. In this study, we evaluated the role of HO-1 in the infection by Leishmania infantum chagasi, the causative agent of VL cases in Brazil. We found that L. chagasi infection or lipophosphoglycan isolated from promastigotes triggered HO-1 production by murine macrophages. Interestingly, cobalt protoporphyrin IX, an HO-1 inductor, increased the parasite burden in both mouse and human-derived macrophages. Upon L. chagasi infection, macrophages from Hmox1 knockout mice presented significantly lower parasite loads when compared with those from wild-type mice. Furthermore, upregulation of HO-1 by cobalt protoporphyrin IX diminished the production of TNF-α and reactive oxygen species by infected murine macrophages and increased Cu/Zn superoxide dismutase expression in human monocytes. Finally, patients with VL presented higher systemic concentrations of HO-1 than healthy individuals, and this increase of HO-1 was reduced after antileishmanial treatment, suggesting that HO-1 is associated with disease susceptibility. Our data argue that HO-1 has a critical role in the L. chagasi infection and is strongly associated with the inflammatory imbalance during VL. Manipulation of HO-1 pathways during VL could serve as an adjunctive therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461696      PMCID: PMC3331931          DOI: 10.4049/jimmunol.1103072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

Review 1.  How do protozoan parasites survive inside macrophages?

Authors:  C Bogdan; M Röllinghoff
Journal:  Parasitol Today       Date:  1999-01

2.  TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar.

Authors:  N A Gomes; C R Gattass; V Barreto-De-Souza; M E Wilson; G A DosReis
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.

Authors:  G F Späth; L Epstein; B Leader; S M Singer; H A Avila; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 4.  Immune responses in kala-azar.

Authors:  Samiran Saha; Smriti Mondal; Antara Banerjee; Jayeeta Ghose; Sudipta Bhowmick; Nahid Ali
Journal:  Indian J Med Res       Date:  2006-03       Impact factor: 2.375

5.  Increased levels of plasma haemoxygenase-1 in prostate cancer.

Authors:  A D Blann; B Balakrishnan; P Ryan; G Y H Lip
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-01-25       Impact factor: 5.554

6.  Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts.

Authors:  J M Coelho-Finamore; V C Freitas; R R Assis; M N Melo; N Novozhilova; N F Secundino; P F Pimenta; S J Turco; R P Soares
Journal:  Int J Parasitol       Date:  2010-11-27       Impact factor: 3.981

7.  Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria.

Authors:  Ana Pamplona; Ana Ferreira; József Balla; Viktória Jeney; György Balla; Sabrina Epiphanio; Angelo Chora; Cristina D Rodrigues; Isabel Pombo Gregoire; Margarida Cunha-Rodrigues; Silvia Portugal; Miguel P Soares; Maria M Mota
Journal:  Nat Med       Date:  2007-05-13       Impact factor: 53.440

8.  Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice.

Authors:  Su Wol Chung; Xiaoli Liu; Alvaro A Macias; Rebecca M Baron; Mark A Perrella
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps.

Authors:  Anderson B Guimarães-Costa; Michelle T C Nascimento; Giselle S Froment; Rodrigo P P Soares; Fernanda N Morgado; Fátima Conceição-Silva; Elvira M Saraiva
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

10.  Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis.

Authors:  Joanna R Santos-Oliveira; Eduardo G Regis; Cássia R B Leal; Rivaldo V Cunha; Patrícia T Bozza; Alda M Da-Cruz
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12
View more
  36 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

2.  Techniques to study phagocytosis and uptake of Leishmania tarentolae by J774 macrophages.

Authors:  Gerald Geroldinger; Marlene Rezk; Rugaia Idris; Victoria Gruber; Matthias Tonner; Rudolf Moldzio; Katrin Staniek; Lianet Monzote; Lars Gille
Journal:  Exp Parasitol       Date:  2019-01-21       Impact factor: 2.011

Review 3.  The different facets of heme-oxygenase 1 in innate and adaptive immunity.

Authors:  Rafael Cardoso Maciel Costa Silva; Luiz Ricardo Vasconcelos; Leonardo Holanda Travassos
Journal:  Cell Biochem Biophys       Date:  2022-08-26       Impact factor: 2.989

4.  RIPK1 and PGAM5 Control Leishmania Replication through Distinct Mechanisms.

Authors:  Nivea Farias Luz; Sakthi Balaji; Kendi Okuda; Aline Silva Barreto; John Bertin; Peter J Gough; Ricardo Gazzinelli; Roque P Almeida; Marcelo T Bozza; Valeria M Borges; Francis Ka-Ming Chan
Journal:  J Immunol       Date:  2016-05-16       Impact factor: 5.422

5.  Acteoside improves survival in cecal ligation and puncture-induced septic mice via blocking of high mobility group box 1 release.

Authors:  Eun Sun Seo; Bo Kang Oh; Jhang Ho Pak; Soon-Ho Yim; Sangilyandi Gurunathan; Young-Pil Kim; Kyung Jin Lee
Journal:  Mol Cells       Date:  2013-04-04       Impact factor: 5.034

Review 6.  The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis.

Authors:  Eduardo P Amaral; Caian L Vinhaes; Deivide Oliveira-de-Souza; Betania Nogueira; Kevan M Akrami; Bruno B Andrade
Journal:  Antioxid Redox Signal       Date:  2020-06-19       Impact factor: 8.401

7.  Leishmania donovani Targets Host Transcription Factor NRF2 To Activate Antioxidant Enzyme HO-1 and Transcriptional Repressor ATF3 for Establishing Infection.

Authors:  Shriya Saha; Shalini Roy; Ananya Dutta; Kuladip Jana; Anindita Ukil
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

8.  Leishmania donovani Metacyclic Promastigotes Impair Phagosome Properties in Inflammatory Monocytes.

Authors:  Christine Matte; Guillermo Arango Duque; Albert Descoteaux
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

9.  Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages.

Authors:  Izabela Coimbra Ibraim; Rafael Ramiro de Assis; Natália Lima Pessoa; Marco Antônio Campos; Maria Norma Melo; Salvatore Joseph Turco; Rodrigo Pedro Soares
Journal:  Parasit Vectors       Date:  2013-03-07       Impact factor: 3.876

10.  Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Katrin D Mayer-Barber; Daniel L Barber; Rathinam Sridhar; Vaithilingam V Banu Rekha; Mohideen S Jawahar; Thomas B Nutman; Alan Sher; Subash Babu
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.